-
Selcia and Cantab Announce Drug Discovery Collaboration
Selcia Limited, the international life sciences CRO, has entered into a drug discovery collaboration with Cantab Anti-Infectives
-
Warwick University Wins Domainex Award for New Chagas Treatment
University of Warwick wins Domainex’s first Discovery STAR Award to Support hunt for new Chagas Disease Treatment
-
Cambridge Research Biochemicals confirms supplier status with contract renewal
Cambridge Research Biochemicals (CRB), the specialist peptide and custom antibody manufacturer based in the North East of England, has demonstrated customer satisfaction with the extension of an important contract in the medical research field.
-
Baby Eva named after pioneering IVF test
First baby born in Scotland using new ground-breaking IVF technology
-
First baby born in the UK using Early Embryo Viability Assessment (EevaTM) test
First baby born in the UK using Early Embryo Viability Assessment (EevaTM) test. Auxogyn at the forefront of revolutionizing IVF treatment.
-
London Bioscience Innovation Centre welcomes HistoIndex as 50th client
London BioScience Innovation Centre welcomes medical imaging company Singapore-based HistoIndex as 50th client.
-
First UK patients enroll in Phase 3 clinical trials of LMTX™ for Alzheimer’s Disease
First UK patients enroll in Phase 3 clinical trials of LMTX™ for Alzheimer’s Disease
-
Auxogyn to Present at European BioEquity Conference in Stockholm
Auxogyn Selected to Present at European BioEquity Conference in Stockholm.
-
Fujifilm Diosynth Biotechnologies Commissions New Cell Banking Facility
Fujifilm Diosynth Biotechnologies commissions new cell banking facility at Billingham, UK site.
-
TauRx Highlights Consequences of Alzheimer’s in Asia
TauRx Chairman Highlights Future Consequences of Alzheimer’s in Asia.